Abstract
Background/aimsTo evaluate the efficacy and safety of the PreserFlo MicroShunt glaucoma device in a multicentre cohort study.MethodsAll consecutive patients who received the microshunt with mitomycin-C (MMC) 0.4 mg/mL from May...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have